{"id":17302,"date":"2025-09-19T21:07:49","date_gmt":"2025-09-19T18:07:49","guid":{"rendered":"https:\/\/testsunucusu.com\/acibadem\/doctor\/izzet-dogan\/"},"modified":"2025-12-10T20:36:04","modified_gmt":"2025-12-10T17:36:04","slug":"izzet-dogan","status":"publish","type":"idel_doctor","link":"https:\/\/acibademinternational.com\/doctor\/izzet-dogan\/","title":{"rendered":"\u0130zzet Do\u011fan"},"content":{"rendered":"

<\/p>\n

\n

Assoc. Prof. \u0130zzet Do\u011fan<\/strong> is an experienced medical oncologist with a strong clinical and academic background. He completed his medical oncology training at Istanbul University, Istanbul Faculty of Medicine in 2021. Currently affiliated with Acibadem Health Group since 2025, he provides patient-centered oncology care and participates in multidisciplinary treatment planning. M.D. Do\u011fan is an active member of the European Society for Medical Oncology (ESMO), the Turkish Society of Medical Oncology, and the Turkish Medical Association, reflecting his commitment to ongoing professional development and adherence to international and national standards in cancer care.<\/p>\n

<\/div>\n

Education<\/strong><\/p>\n

    \n
  • 2021<\/span> Istanbul University Istanbul Faculty of Medicine Medical Oncology<\/span><\/li>\n
  • 2013<\/span> Ankara University Faculty of Medicine Internal Medicine<\/span><\/li>\n
  • 2008<\/span> Hacettepe University Faculty of Medicine<\/span><\/li>\n<\/ul>\n

    Experience<\/strong><\/p>\n

      \n
    • 2025<\/span> Acibadem Health Group<\/span><\/li>\n
    • 2023<\/span> Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital \/ Medical Oncology \u2013 Associate Professor<\/span><\/li>\n
    • 2021 \u2013 2022<\/span> Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital \/ Medical Oncology Specialist<\/span><\/li>\n
    • 2018 \u2013 2021<\/span> Istanbul University Istanbul Faculty of Medicine \/ Department of Internal Medicine \/ Division of Medical Oncology) \/ Medical Oncology \u2013 Research Assistant<\/span><\/li>\n
    • 2015<\/span> Antalya Training and Research Hospital \/ Internal Medicine Specialist<\/span><\/li>\n
    • 2014<\/span> K\u00fctahya Military Hospital \/ Internal Medicine Specialist<\/span><\/li>\n
    • 2013<\/span> Aksaray State Hospital \/ Internal Medicine Specialist<\/span><\/li>\n
    • 2009 \u2013 2013<\/span> Ankara University Faculty of Medicine, Department of Internal Medicine \/ Department of Internal Medicine \/ Internal Medicine Research Assistant<\/span><\/li>\n
    • 2008 \u2013 2009<\/span> Korgan \u00c7ay\u0131rkent Health Center, Ordu \/ General Practitioner<\/span><\/li>\n<\/ul>\n

      Memberships<\/strong><\/p>\n

        \n
      • European Society for Medical Oncology (ESMO)<\/span><\/li>\n
      • Turkish Society of Medical Oncology<\/span><\/li>\n
      • Turkish Medical Association<\/span><\/li>\n<\/ul>\n

        Publications<\/strong><\/p>\n

          \n
        • Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process<\/strong>
          \n(2023). Oncology, S. Karger AG, 101, Doi: 10.1159\/000529030 Do\u011fan \u0130zzet, K\u0131z\u0131lda\u011f Y\u0131rg\u0131n \u0130nci, \u00d6zkurt Selnur, \u0130bi\u015f Kamuran, Vatansever Sezai, Saip P\u0131nar Mualla, Ayd\u0131ner Adnan<\/li>\n
        • Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients.<\/strong>
          \nDo\u011fan \u0130zzet, \u00d6nder Semen, T\u00fckenmez Mustafa, Cabio\u011flu Neslihan, K\u00fc\u00e7\u00fcc\u00fck Nezihe Seden, M\u00fcsl\u00fcmo\u011flu Mahmut, \u00d6zmen Vahit, Saip P\u0131nar Mualla, \u0130\u011fci Abdulla Journal of Cancer Research and Clinical Oncology, Doi: 10.1007\/s00432-023-05276-y<\/li>\n
        • Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression<\/strong>
          \n(2023). Scientific Reports 2023(13), Doi: 10.1038\/s41598-023-35715-2 Do\u011fan \u0130zzet, Ayd\u0131n Esra, Khanmammadov Nijat, Paksoy Nail, Saip P\u0131nar Mualla, Ayd\u0131ner Adnan<\/li>\n
        • Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Grou<\/strong>
          \nDo\u011fan \u0130zzet, Aksoy Sercan, \u00c7akar Burcu, Ba\u015faran G\u00fcl, Ercelep \u00d6zlem, Mandel Nil Molinas, Korkmaz Taner, G\u00f6kmen Erhan, Ayd\u0131ner Adnan, Saip P\u0131nar Mualla, (2023). Cancers, MDPI, 15, Doi: 10.3390\/cancers15061667<\/li>\n
        • Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.<\/strong>
          \nJournal of Cancer Research and Therapeutics, 1-5., Doi: 10.4103\/jcrt.jcrt_972_22 Do\u011fan \u0130zzet, \u0130riba\u015f \u00c7elik Ay\u00e7a, Paksoy Nail, Vatansever Sezai, Ba\u015faran Mert<\/li>\n
        • Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma.<\/strong>
          \n(2022). Journal of Chemotherapy, Doi: 10.1080\/1120009X.2022.2104295 Do\u011fan \u0130zzet, \u0130riba\u015f \u00c7elik Ay\u00e7a, Ahmed Melin Aydan, Ba\u015faran Mert<\/li>\n
        • Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2\/Neu-positive Metastatic Gastric Cancer.<\/strong>
          \n(2022). Journal of the College of Physicians and Surgeons Pakistan, 32(8), 1014-1019., Doi: 10.29271\/jcpsp.2022.08.1014 Do\u011fan \u0130zzet, Karabulut Senem, Ta\u015ftekin Didem, Ferhato\u011flu Ferhat, Paksoy Nail, \u015eakar Burak<\/li>\n
        • The frequency and prognostic significance of ABO\/Rh blood groups in male breast cancer patients: a multicenter study.<\/strong>
          \n(2022). Medicine, 101(35), 1-6., Doi: 10.1097\/MD.0000000000030147 Do\u011fan \u0130zzet, Ayhan Murat, G\u00fcrb\u00fcz Mustafa, K\u00fc\u00e7\u00fckarda Ahmet, Ayd\u0131n Esra, \u00dcr\u00fcn Y\u00fcksel, \u00c7i\u00e7in \u0130rfan, Saip P\u0131nar Mualla<\/li>\n
        • Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC.<\/strong>
          \n(2022). Medicine, 101(34), 1-6., Doi: 10.1097\/md.0000000000030188 Do\u011fan \u0130zzet, G\u00fcrb\u00fcz Mustafa, Paksoy Nail, Ferhato\u011flu Ferhat, Vatansever Sezai, Saip P\u0131nar Mualla, Demirkaz\u0131k Ahmet, Ayd\u0131ner Adnan<\/li>\n
        • Hormonal Therapy in Pretreated Patients With Recurrent Ovary Granulosa Cell Tumor<\/strong>
          \nJournal of Pharmacy Practice, Doi: 10.1177\/08971900221129679 Do\u011fan \u0130zzet, Ayd\u0131n Esra, Topuz Samet, Saip P\u0131nar Mualla, Saliho\u011flu Mehmet Yavuz, Ayd\u0131ner Adnan<\/li>\n<\/ul>\n<\/div>\n","protected":false},"featured_media":17303,"template":"","categories":[16,18,841,4,842],"class_list":["post-17302","idel_doctor","type-idel_doctor","status-publish","has-post-thumbnail","hentry","category-atakent-hospital","category-bakirkoy-hospital","category-breast-clinic-clinical-service","category-doctors","category-oncology"],"_links":{"self":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor\/17302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor"}],"about":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/types\/idel_doctor"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media\/17303"}],"wp:attachment":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media?parent=17302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/categories?post=17302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}